Your shopping cart


Total (VAT incl.)

VAT (21%)
You have not added any reports to the cart yet.
Request reports
If you prefer to place your order via e-mail
contact us at: digital@azierta.com

Events and news

Home > Blog > Toxicology

Azierta completes the webinar ''Nitrosamine impurities: present, past and future'' with a great reception from the audience

The webinar discussed the essential aspects of nitrosamines impurities, which can be carcinogenic and require manufacturers to evaluate their products.

This Tuesday 27th October Azierta organized a professional webinar on nitrosamines impurities with 231 attendees. Ana Maria Castro, Industrial Area Manager, and Javier Fernandez, Senior Toxicology Officer, presented the content in two different blocks with special attention to the control and surveillance strategy.

The purpose of this webinar, which was developed online, is to provide guidance on how Marketing Authorisation Holders (MAHs) should conduct a proper analysis of products at risk of containing nitrosamines impurities, which could lead manufacturers to change the manufacturing process. The FDA and the EMA are providing MAHs with guidance on how to comply with this measure after it has been demonstrated that nitrosamines impurities can be carcinogenic.

New deadlines have been agreed for mandatory risk assessment, 31 March 2021 for chemical medicines and 1 July 2021 for biological medicines.

Azierta has a professional and multidisciplinary team of experts with great experience in the implementation of ICH Q9 quality management regulations and in the evaluation and control of mutagenic impurities according to ICH M7. It also has a specialised toxicological support area accredited by AETOX, EUROTOX and ERT.

Azierta is a consultancy firm specialised in Science and Health that is committed to promoting the relationship between science and the business environment through the "Science to Business" concept.




Related posts

What do you need for the cultivation of medicinal cannabis in...

What do you need for the cultivation of medicinal cannabis in Europe?

Read more

Azierta Webinar on the new requirements for Safety Data Sheets...

Azierta Webinar on the new requirements for Safety Data Sheets that will come into force on 1 January 2021

Read more

Leading innovation in pharma & health

100 professionals

Over 100 professionals

500 clients

Over 2,000 clients

9 year experience

10 years of experience


Leading innovation

Client oriented

100% client oriented


We help you in everything you need. Contact us by filling out the form or book an appointment for a video call with one of our experts.

We use "cookies" to improve your experience on our site. Cookies enable us to tailor messages and display ads to your interests. They also help us understand how our site is being used. By continuing to use our site you consent to use our cookies.

We are at your complete disposal for any inquiry

Thank you for getting in touch! We will contact you as soon as possible to help you out
There has been an error while submitting your form, please try again, or call us at 912 77 10 76